BE812816A - Vaccin contre le virus herpes simplex type 2 et procede pour saproduction et son utilisation - Google Patents

Vaccin contre le virus herpes simplex type 2 et procede pour saproduction et son utilisation

Info

Publication number
BE812816A
BE812816A BE142433A BE142433A BE812816A BE 812816 A BE812816 A BE 812816A BE 142433 A BE142433 A BE 142433A BE 142433 A BE142433 A BE 142433A BE 812816 A BE812816 A BE 812816A
Authority
BE
Belgium
Prior art keywords
vaccine
production
herpes simplex
simplex type
type
Prior art date
Application number
BE142433A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE812816A publication Critical patent/BE812816A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BE142433A 1973-03-30 1974-03-26 Vaccin contre le virus herpes simplex type 2 et procede pour saproduction et son utilisation BE812816A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1530773A GB1390467A (en) 1973-03-30 1973-03-30 Vaccination method using temperature sensitive virus mutants

Publications (1)

Publication Number Publication Date
BE812816A true BE812816A (fr) 1974-09-26

Family

ID=10056766

Family Applications (1)

Application Number Title Priority Date Filing Date
BE142433A BE812816A (fr) 1973-03-30 1974-03-26 Vaccin contre le virus herpes simplex type 2 et procede pour saproduction et son utilisation

Country Status (10)

Country Link
US (1) US3897549A (hu)
JP (1) JPS6035327B2 (hu)
BE (1) BE812816A (hu)
CA (1) CA1021261A (hu)
DE (1) DE2415353A1 (hu)
FR (1) FR2223004B1 (hu)
GB (1) GB1390467A (hu)
HU (1) HU169253B (hu)
NL (1) NL7404054A (hu)
ZA (1) ZA741441B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus
US4618493A (en) * 1982-10-13 1986-10-21 Smithkline-Rit Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4848621A (hu) * 1971-10-20 1973-07-10
DE2215728C3 (de) * 1972-03-30 1979-02-15 Stickl, Helmut, Prof. Dr.Med., 8033 Krailling Arzneimittel zur Behandlung von Herpes simplex

Also Published As

Publication number Publication date
AU6708674A (en) 1975-09-25
JPS6035327B2 (ja) 1985-08-14
FR2223004B1 (hu) 1978-01-06
US3897549A (en) 1975-07-29
DE2415353A1 (de) 1974-10-03
FR2223004A1 (hu) 1974-10-25
HU169253B (hu) 1976-10-28
CA1021261A (en) 1977-11-22
JPS5029736A (hu) 1975-03-25
NL7404054A (hu) 1974-10-02
GB1390467A (en) 1975-04-16
ZA741441B (en) 1975-02-26
DE2415353C2 (hu) 1987-10-01

Similar Documents

Publication Publication Date Title
CY1065A (en) Contraceptive method and pack
BE744810A (fr) Procede de preparation d'alcynols et d'alcyne-diols
BE858992A (fr) Procede de preparation de vaccins
BE815418A (fr) Carbanilides et procede pour leur preparation
IT1017280B (it) Processo per la preparazione di n vinilcarbonamidi secondarie
YU109580A (en) Process for preparing new 1-phenoxy-2-hydroxy-3-propargylamino propanes and acid addition salts thereof
BE823973A (fr) Beta-aminoethylsilanes et leur procede de preparation
CY1018A (en) Pseudotrisaccharides and methods for their production
BE768119A (fr) Procede de preparation de cycloalcanols et de cycloalcanones
BE820385A (fr) D-homo-steroides et leur procede de preparation
ZA741812B (en) New amines and process for their preparation
AU467558B2 (en) Light weight concrete and process for its production
BE812816A (fr) Vaccin contre le virus herpes simplex type 2 et procede pour saproduction et son utilisation
BE761222A (fr) Nouvelles glycosidyl-pteridines et procede pour leur preparation
AU7587674A (en) Infouenza vaccines
FR2281366A1 (fr) Ureylene-thiophanes et leurs derives, et procede pour leur preparation
BE813772A (fr) Fortimycine b et son procede de preparation
BE809984A (fr) Colorants et leur procede de preparation
AU2183370A (en) Multivalent vaccines and process for their preparation
BE774498A (fr) Procede de preparation de monofluoro-dichloromethane et de difluoro-monochloromethane
ZA742378B (en) New amines and process for their manufacture
AU2537371A (en) New amines and process for their manufacture
AU7096274A (en) Vaccine
CA834244A (en) Process for preparing continuously higher molecular secondary and tertiary amines
AU486997B2 (en) Herpes simplex type 2 virus vaccine and method of production and use

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITH KLINE-RIT

Effective date: 19890331